STTK compared with BFS: revenue, margins and what each company keeps, and the suppliers and customers both name

STTKShattuck Labs, Inc.

Mkt capRevenueRevenue

BFSSaul Centers, Inc.

Mkt capRevenueRevenue

Compare

STTKShattuck Labs, Inc.

BFSSaul Centers, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

rebased to 0%

STTK, solidBFS, dashed

Supply-chain overlap

Revenue flow

STTK: latest quarter is a loss; flow not drawable. BFS: latest quarter not drawable.Method ›

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only STTK 4

—Kemwell Biopharma Privateunlistedsupplier

—ImmunoGenunlistedcustomer

—Kayak Therapeuticsunlistedcustomer

—Ono Pharmaceuticalunlistedcustomer

Shared 0

No shared counterparties.

Only BFS 3

—Giant Foodunlistedcustomer

—Wegmansunlistedcustomer

—Publixunlistedcustomer

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

STTKShattuck Labs, Inc.

5.12· pre 5.12· delayed

Mkt cap$516.9MRevenue$1MQ3 FY25Revenue—

BFSSaul Centers, Inc.

29.16· pre 29.16· delayed

Pre-marketNov 4 '26delayed

Mkt cap$719.3MRevenue$77MQ2 FY26Revenue$290MFY25

Compare

Pre-marketNov 4 '26delayed

STTKShattuck Labs, Inc.

BFSSaul Centers, Inc.

5.12pre 5.12delayed

Price

29.16pre 29.16delayed

$516.9M

Mkt cap

$719.3M

Q3 FY25$1M

Revenue

$77MQ2 FY26

—

Revenue

$290MFY25

STTK5.12vsBFS29.16Pre-marketNov 4 '26delayed